Search

Abstract: Developments in human cellular reprogramming now allow for the generation of human neurons for in vitro disease modelling. This technique has since been used for chemotherapy-induced peripheral neuropathy (CIPN) research, resulting in the description of numerous CIPN models constructed from human neurons. This systematic review provides a critical analysis of available models and their methodological considerations (ie, used cell type and source, CIPN induction strategy, and validation method) for prospective researchers aiming to incorporate human in vitro models of CIPN in their research. The search strategy was developed with assistance from a clinical librarian and conducted in MEDLINE (PubMed) and Embase (Ovid) on September 26, 2023. Twenty-six peer-reviewed experimental studies presenting original data about human reprogrammed nonmotor neuron cell culture systems and relevant market available chemotherapeutics drugs were included. Virtually, all recent reports modeled CIPN using nociceptive dorsal root ganglion neurons. Drugs known to cause the highest incidence of CIPN were most used. Furthermore, treatment effects were almost exclusively validated by the acute effects of chemotherapeutics on neurite dynamics and cytotoxicity parameters, enabling the extrapolation of the half-maximal inhibitory concentration for the 4 most used chemotherapeutics. Overall, substantial heterogeneity was observed in the way studies applied chemotherapy and reported their findings. We therefore propose 6 suggestions to improve the clinical relevance and appropriateness of human cellular reprogramming-derived CIPN models., (Copyright © 2024 The Author(s). Published by Wolters Kluwer Health, Inc. on behalf of the International Association for the Study of Pain.)

Current test strategies to identify thyroid hormone (TH) system disruptors are inadequate for conducting robust chemical risk assessment required for regulation. The tests rely heavily on histopathological changes in rodent thyroid glands or measuring changes in systemic TH levels, but they lack specific new approach methodologies (NAMs) that can adequately detect TH-mediated effects. Such alternative test methods are needed to infer a causal relationship between molecular initiating events and adverse outcomes such as perturbed brain development. Although some NAMs that are relevant for TH system disruption are available-and are currently in the process of regulatory validation-there is still a need to develop more extensive alternative test batteries to cover the range of potential key events along the causal pathway between initial chemical disruption and adverse outcomes in humans. This project, funded under the Partnership for the Assessment of Risk from Chemicals (PARC) initiative, aims to facilitate the development of NAMs that are specific for TH system disruption by characterizing in vivo mechanisms of action that can be targeted by in embryo/in vitro/in silico/in chemico testing strategies. We will develop and improve human-relevant in vitro test systems to capture effects on important areas of the TH system. Furthermore, we will elaborate on important species differences in TH system disruption by incorporating non-mammalian vertebrate test species alongside classical laboratory rat species and human-derived in vitro assays., Competing Interests: The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest., (Copyright © 2023 Ramhøj, Axelstad, Baert, Cañas-Portilla, Chalmel, Dahmen, De La Vieja, Evrard, Haigis, Hamers, Heikamp, Holbech, Iglesias-Hernandez, Knapen, Marchandise, Morthorst, Nikolov, Nissen, Oelgeschlaeger, Renko, Rogiers, Schüürmann, Stinckens, Stub, Torres-Ruiz, Van Duursen, Vanhaecke, Vergauwen, Wedebye and Svingen.)

Many drug discovery programmes, particularly for infectious diseases, are conducted phenotypically. Identifying the targets of phenotypic screening hits experimentally can be complex, time-consuming, and expensive. However, it would be valuable to know what the molecular target(s) is, as knowledge of the binding pose of the hit molecule in the binding site can facilitate the compound optimisation. Furthermore, knowing the target would allow de-prioritisation of less attractive chemical series or molecular targets. To generate target-hypotheses for phenotypic active compounds, an in silico platform was developed that utilises both ligand and protein-structure information to generate a ranked set of predicted molecular targets. As a result of the web-based workflow the user obtains a set of 3D structures of the predicted targets with the active molecule bound. The platform was exemplified using Mycobacterium tuberculosis, the causative organism of tuberculosis. In a test that we performed, the platform was able to predict the targets of 60% of compounds investigated, where there was some similarity to a ligand in the protein database., (Copyright © 2019 The Authors. Published by Elsevier Inc. All rights reserved.)

The design of a single drug molecule that is able to simultaneously and specifically interact with multiple biological targets is gaining major consideration in drug discovery. However, the rational design of drugs with a desired polypharmacology profile is still a challenging task, especially when these targets are distantly related or unrelated. In this work, we present a computational approach aimed at the identification of suitable target combinations for multitarget drug design within an ensemble of biologically relevant proteins. The target selection relies on the analysis of activity annotations present in molecular databases and on ligand-based virtual screening. A few target combinations were also inspected with structure-based methods to demonstrate that the identified dual-activity compounds are able to bind target combinations characterized by remote binding site similarities. Our approach was applied to the heat shock protein 90 (Hsp90) interactome, which contains several targets of key importance in cancer. Promising target combinations were identified, providing a basis for the computational design of compounds with dual activity. The approach may be used on any ensemble of proteins of interest for which known inhibitors are available.

Profiling of compounds against target families has become an important approach in pharmaceutical research for the identification of hits and analysis of selectivity and promiscuity patterns. We report on modeling of profiling experiments involving 429 potential inhibitors and a panel of 24 different kinases using support vector machine (SVM) techniques and naïve Bayesian classification. The experimental matrix contained many different activity profiles. SVM predictions achieved overall high accuracy due to consistently low false-positive and consistently high true-negative rates. However, predictions for promiscuous inhibitors were affected by false-negative rates. Combined target-based SVM classifiers reached or exceeded the performance of SVM profile prediction methods and were superior to Bayesian classification. The classifiers displayed different prediction characteristics including diverse combinations of false-positive and true-negative rates. Predicted and experimentally observed compound activity profiles were compared in detail, revealing activity patterns modeled with different accuracy., (© 2014 John Wiley & Sons A/S.)

Active compounds can participate in different local structure-activity relationship (SAR) environments and introduce different degrees of local SAR discontinuity, depending on their structural and potency relationships in data sets. Such SAR features have thus far mostly been analyzed using descriptive approaches, in particular, on the basis of activity landscape modeling. However, compounds in different local SAR environments have not yet been predicted. Herein, we adapt the emerging chemical patterns (ECP) method, a machine learning approach for compound classification, to systematically predict compounds with different local SAR characteristics. ECP analysis is shown to accurately assign many compounds to different local SAR environments across a variety of activity classes covering the entire range of observed local SARs. Control calculations using random forests and multiclass support vector machines were carried out and a variety of statistical performance measures were applied. In all instances, ECP calculations yielded comparable or better performance than controls. The approach presented herein can be applied to predict compounds that complement local SARs or prioritize compounds with different SAR characteristics.

Introduction: Support vector machines (SVMs) are supervised machine learning algorithms for binary class label prediction and regression-based prediction of property values. In recent years, SVMs have become increasingly popular for drug discovery-relevant applications such as compound classification, the search for novel active compounds and property predictions., Areas Covered: The authors provide the readers with a brief introduction of SVM theory and discuss the kernel functions designed for drug discovery applications. The authors also review the different types of SVM applications in drug discovery, looking at particular case studies. Furthermore, the authors discuss the recent hybrid methods developed that incorporate SVM modeling in different ways., Expert Opinion: SVMs are currently among the best-performing approaches for chemical and biological property prediction and the computational identification of active compounds. It is anticipated that their use in drug discovery will further increase. Indeed, this will also include the development of SVM-based meta-classifiers that combine different approaches and exploit their individual strengths and complementarity.

The choice of negative training data for machine learning is a little explored issue in chemoinformatics. In this study, the influence of alternative sets of negative training data and different background databases on support vector machine (SVM) modeling and virtual screening has been investigated. Target-directed SVM models have been derived on the basis of differently composed training sets containing confirmed inactive molecules or randomly selected database compounds as negative training instances. These models were then applied to search background databases consisting of biological screening data or randomly assembled compounds for available hits. Negative training data were found to systematically influence compound recall in virtual screening. In addition, different background databases had a strong influence on the search results. Our findings also indicated that typical benchmark settings lead to an overestimation of SVM-based virtual screening performance compared to search conditions that are more relevant for practical applications.

A compound pathway model is introduced to monitor SAR progression in compound data sets. Pathways are formed by sequences of structurally analogous compounds with stepwise increasing potency that ultimately yield highly potent compounds. Hence, the model was designed to mimic compound optimization efforts. Different pathway categories were defined. Pathways originating from any active compound in a data set were systematically identified including compounds forming activity cliffs. The relative frequency of activity cliff-dependent and -independent pathways was determined and compared. In 23 of 39 different compound data sets that qualified for our analysis, significant differences in the relative frequency of activity cliff-dependent and -independent pathways were observed. In 17 of these 23 data sets, activity cliff-dependent pathways occurred with higher relative frequency than cliff-independent pathways. In addition, pathways originating from the majority of activity cliff compounds displayed desired SAR progression, reflecting SAR information gain associated with activity cliffs.

Activity cliffs are defined as pairs of structurally similar compounds with a significant difference in potency. These compound pairs have high SAR information content because they represent small structural changes leading to large potency alterations. Accordingly, activity cliffs are of prime interest for SAR exploration and compound optimization. It is currently unknown to what extent activity cliff information is utilized in practical medicinal chemistry. Therefore, we have assembled 56 compound data sets that evolved over time and searched for analogues of activity cliff-forming compounds with further increased potency. For ∼75% of all activity cliffs, there was no evidence for further chemical exploration. For ∼25% of all cliffs, potency progression was detected. In total, for ∼15% of all activity cliffs, positive cliff progression was observed that often involved multiple analogues. Given these findings, chemically unexplored activity cliffs should provide significant opportunities for further study in medicinal chemistry.

Using support vector machine (SVM) ranking, a complex multi-class prediction task has been investigated involving sets of compounds that were active against related targets and represented all possible combinations of single-, dual-, and triple-target activities. Standard SVM models were not capable of differentiating compounds with overlapping yet distinct activity profiles. To address this problem, we designed differentially weighted SVM linear combinations that were found to preferentially detect compounds with desired activity profiles and deprioritize others. Hence, combining independently derived SVM models using negative and positive linear weighting factors balanced relative contributions from individual reference sets and successfully distinguished between compounds with overlapping activity profiles.

We provide a future perspective of the virtual screening field. A number of challenges will be highlighted that virtual screening will likely face when compound data will further grow at or beyond current rates and when much more target information will become available. These challenges go beyond computational efficiency issues (that will of course also play a critical role). For example, for structure-based approaches, the accuracy of scoring functions and energy calculations will need to be improved. For ligand-based approaches, the compound class-dependence of similarity methods needs to be further explored and relationships between molecular similarity and activity similarity need to be established. We also comment on the current and future value of virtual screening. Opportunities for further development in a postgenome era are also discussed. It is hoped that some of the views and hypotheses we articulate might stimulate further discussion about the virtual screening field going forward., (© 2012 John Wiley & Sons A/S.)

Fingerprints (FPs) are bit or integer string representations of molecular structure and properties, and are popular descriptors for chemical similarity searching. A major goal of similarity searching is the identification of novel active compounds on the basis of known reference molecules. In this review recent FP design and engineering strategies are discussed. New types of FPs continue to be replaced, often applying different design principles. FP engineering techniques have recently been introduced to further improve search performance and computational efficiency and elucidate mechanisms by which FPs recognize active compounds. In addition, through feature selection and hybridization techniques, standard FPs have been transformed into compound class-specific versions with further increased search performance. Moreover, scaffold hopping mechanisms have been explored. FPs will continue to play an important role in the search for novel active compounds.

Activity cliffs are formed by pairs of structurally similar compounds that act against the same target but display a significant difference in potency. Such activity cliffs are the most prominent features of activity landscapes of compound data sets and a primary focal point of structure-activity relationship (SAR) analysis. The search for activity cliffs in various compound sets has been the topic of a number of previous investigations. So far, activity cliff analysis has concentrated on data mining for activity cliffs and on their graphical representation and has thus been descriptive in nature. By contrast, approaches for activity cliff prediction are currently not available. We have derived support vector machine (SVM) models to successfully predict activity cliffs. A key aspect of the approach has been the design of new kernels to enable SVM classification on the basis of molecule pairs, rather than individual compounds. In test calculations on different data sets, activity cliffs have been accurately predicted using specifically designed structural representations and kernel functions.

In independent studies it has previously been demonstrated that two-dimensional (2D) fingerprints have scaffold hopping ability in virtual screening, although these descriptors primarily emphasize structural and/or topological resemblance of reference and database compounds. However, the mechanism by which such fingerprints enrich structurally diverse molecules in database selection sets is currently little understood. In order to address this question, similarity search calculations on 120 compound activity classes of varying structural diversity were carried out using atom environment fingerprints. Two feature selection methods, Kullback-Leibler divergence and gain ratio analysis, were applied to systematically reduce these fingerprints and generate alternative versions for searching. Gain ratio is a feature selection method from information theory that has thus far not been considered in fingerprint analysis. However, it is shown here to be an effective fingerprint feature selection approach. Following comparative feature selection and similarity searching, the compound recall characteristics of original and reduced fingerprint versions were analyzed in detail. Small sets of fingerprint features were found to distinguish subsets of active compounds from other database molecules. The compound recall of fingerprint similarity searching often resulted from a cumulative detection of distinct compound subsets by different fingerprint features, which provided a rationale for the scaffold hopping potential of these 2D fingerprints.

A large-scale similarity search investigation has been carried out on 266 well-defined compound activity classes extracted from the ChEMBL database. The analysis was performed using two widely applied two-dimensional (2D) fingerprints that mark opposite ends of the current performance spectrum of these types of fingerprints, i.e., MACCS structural keys and the extended connectivity fingerprint with bond diameter four (ECFP4). For each fingerprint, three nearest neighbor search strategies were applied. On the basis of these search calculations, a similarity search profile of the ChEMBL database was generated. Overall, the fingerprint search campaign was surprisingly successful. In 203 of 266 test cases (∼76%), a compound recovery rate of at least 50% was observed with at least the better performing fingerprint and one search strategy. The similarity search profile also revealed several general trends. For example, fingerprint searching was often characterized by an early enrichment of active compounds in database selection sets. In addition, compound activity classes have been categorized according to different similarity search performance levels, which helps to put the results of benchmark calculations into perspective. Therefore, a compendium of activity classes falling into different search performance categories is provided. On the basis of our large-scale investigation, the performance range of state-of-the-art 2D fingerprinting has been delineated for compound data sets directed against a wide spectrum of pharmaceutical targets.

Support vector machine modeling has become increasingly popular in chemoinformatics. Recently, several advanced support vector machine applications have been reported including, among others, multitask learning for ligand-target prediction. Here, we introduce another support vector machine approach to add compound potency information to similarity searching and enrich database selection sets with potent hits. For this purpose, we introduce a structure-activity kernel function and a potency-oriented support vector machine linear combination approach. Using fingerprint descriptors, potency-directed support vector machine searching has been successfully applied to four high-throughput screening data sets, and different support vector machine strategies have been compared. For potency-balanced compound reference sets, potency-directed support vector machine searching meets or exceeds recall rates of standard support vector machine calculations but detects many more potent hits., (© 2010 John Wiley & Sons A/S.)